Rosen Law Firm announces a class action lawsuit for purchasers of American Depositary Shares of Mereo BioPharma Group plc, with a lead plaintiff deadline of April 6, 2026. Investors may be entitled to compensation due to misleading statements regarding the company's Phase 3 clinical trials.
Related articles
Press ReleaseSeptember 16, 2026
ASSA ABLOY
ASSA ABLOY acquires PACLOCK in the US
September 16, 2026
Press ReleaseSeptember 16, 2026
MySize
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv
Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform
September 16, 2026
← Back to all articles
Generated by Olivia 6